Skip to main content
. 2019 Sep 6;64(6):955–964. doi: 10.1007/s00484-019-01785-z

Table 5.

Distribution of the scores of separate areas of SF-36 questionnaire before, after treatment, and 1 month after treatment (stages I, II, III), with respect to groups of subjects

Group I (n = 32) Group II (n = 30) Group III (n = 30) p value
A (SD), score
Physical activity
  Stage I 40.2 (20.3) 43.4 (18.4) 39.5 (16.7) F = 0.357, p = 0.701
  Stage II 54.3 (23.5) 52.0 (16.2) 43.7 (16.2) F = 2.552, p = 0.084
  Stage III 53.5 (25.1) 55.0 (17.2) 45.3 (16.3) F = 2.021, p = 0.132
Restriction of activity due to physical problems
  Stage I 43.0 (41.8) 59.2 (41.3) 54.3 (42.8) χ2 = 2.553, p = 0.279
  Stage II 68.3 (35.3) 75.9 (32.4) 61.2 (38.1) χ2 = 2.072, p = 0.355
  Stage III 68.0 (37.7) 72.4 (34.9) 60.0 (38.1) χ2 = 1.462, p = 0.481
Pain
  Stage I 58.7 (19.3) 52.5 (16.8) 58.5 (16.5) χ2 = 2.219, p = 0.33
  Stage II 43.4 (18.2) 42.8 (16.5) 54.4 (19.9) F = 2.800, p = 0.056
  Stage III 43.4 (21.3) 39.8 (17.2) 51.5 (22.7) F = 2.492, p = 0.086
Overall health assessment
  Stage I 55.8 (15.7) 52.5 (11.4) 50.7 (15.7) F = 0.999, p = 0.372
  Stage II 51.2 (12.4) 51.2 (12.4) 49.3 (16.1) F = 0.180, p = 0.835
  Stage III 52.1 (13.3) 46.7 (12.1) 52.7 (16.2) F = 1.611, p = 0.206
Energy levels/vitality
  Stage I 34.8 (6.4) 32.2 (8.3) 34.3 (11.4) χ2 = 2.172, p = 0.338
  Stage II 35.8 (7.4) 32.8 (8.4) 33.8 (10.8) χ2 = 2.461, p = 0.292
  Stage III 35.8 (6.0) 33.6 (7.9) 33.5 (10.5) χ2 = 1.32, p = 0.517
Social function
  Stage I 41.5 (7.7) 41.9 (8.6) 41.5 (13.4) χ2 = 0.478, p = 0.787
  Stage II 42.7 (8.7) 42.5 (6.0) 41.5 (13.4) χ2 = 1.291, p = 0.524
  Stage III 42.2 (9.4) 41.4 (8.3) 43.7 (14.6) χ2 = 0.19, p = 0.909
Restriction of activity due to emotional disorders
  Stage I 72.9 (39.2) 75.6 (36.0) 74.7 (34.1) χ2 = 0.057, p = 0.972
  Stage II 86.2 (30.5) 78.2 (34.8) 78.2 (32.5) χ2 = 3.313, p = 0.191
  Stage III 83.3 (33.1) 82.8 (32.9) 75.6 (34.9) χ2 = 1.887, p = 0.389
Emotional state
  Stage I 38.1 (5.5) 38.3 (7.4) 38.0 (7.8) χ2 = 0.143, p = 0.931
  Stage II 41.7 (7.3) 39.8 (8.3) 38.8 (8.7) F = 0.985, p = 0.378
  Stage III 40.9 (5.7) 37.5 (7.7) 40.1 (9.1) χ2 = 5.531, p = 0.063

Group I, provided with bath procedures; group II, provided with mud procedures; A, average; SD, standard deviation; F, by Fisher test; χ2, by Kruskal–Wallis test